Daily Mail reports Tekmira is a potential takeover target for at least four drug companies, including GlaxoSmithKline (GSK and Shire.
Tekmira is developing treatments for the Ebola virus, which has been breaking out since it appeared in a village in Guinea in December.
The stock was up 10.38% to $21.80 at 11:11 a.m. More than 4.7 million shares had changed hands, compared to the average volume of 2,417,160.TKMR data by YCharts
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.